CompletedNCT07164924
Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility
Studying Neuromyelitis Optica
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Clermont-Ferrand
- Principal Investigator
- Pierre ClavelouCHU de Clermont-Ferrand
- Intervention
- blood sample to analyse AMH level on the serum(biological)
- Enrollment
- 800 enrolled
- Eligibility
- 18-35 years · FEMALE
- Timeline
- 2018 – 2024
Study locations (27)
- CHU Amiens, Amiens, France
- CHU Besancon, Besançon, France
- CHU Bordeaux, Bordeaux, France
- CHU Caen, Caen, France
- CHU Clermont-Ferrand, Clermont-Ferrand, France
- AP-HP - Créteil, Créteil, France
- CHU Dijon, Dijon, France
- CHU Grenoble, Grenoble, France
- CHU Lille, Lille, France
- CHU Limoges, Limoges, France
- Hospices Civils de Lyon, Lyon, France
- AP-HM, Marseille, France
- CHU Montpellier, Montpellier, France
- CHU Nancy, Nancy, France
- CHU Nantes, Nantes, France
- +12 more locations on ClinicalTrials.gov
Collaborators
Observatoire Français de la sclérose en plaques (OFSEP) · Roche Diagnostic Ltd. · ARSEP foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07164924 on ClinicalTrials.govOther trials for Neuromyelitis Optica
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT05909761Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During PregnancyAmgen
- RECRUITINGPHASE3NCT05199688A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)Hoffmann-La Roche
- RECRUITINGPHASE4NCT07420296Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum DisorderTianjin Medical University General Hospital
- RECRUITINGNCT06885957Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSDTongji Hospital
- RECRUITINGPHASE1NCT06620809The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum DisordersTongji Hospital
- RECRUITINGNANCT06865274Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNANCT06780709Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSDIcahn School of Medicine at Mount Sinai
- ACTIVE NOT RECRUITINGPHASE3NCT06724809Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSDAlexion Pharmaceuticals, Inc.